ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction

Sebastian J Reinstadler1, Anett Baum2, Karl-Philipp Rommel3

  • 1Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, University of Lübeck, Lübeck, Germany Cardiology and Angiology, University Clinic of Internal Medicine III, Medical University of Innsbruck, Innsbruck, Austria.

Insights

In ST-elevation myocardial infarction (STEMI) patients, incomplete resolution of ST-segment depression (STD-R) after PCI indicates greater heart damage. This finding independently predicts major adverse cardiac events within 12 months.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • ST-elevation myocardial infarction (STEMI) often presents with reciprocal ST-segment depression.
  • The prognostic significance of ST-segment depression resolution (STD-R) in STEMI is not fully understood.
  • Evaluating STD-R may offer insights into myocardial injury and patient outcomes.

Purpose of the Study:

  • To assess the association between STD-R and myocardial injury markers in STEMI patients.
  • To determine the prognostic value of STD-R in acute reperfused STEMI.
  • To investigate the relationship between STD-R and cardiac damage using cardiac magnetic resonance (CMR).

Main Methods:

  • 611 STEMI patients were included in a multicenter CMR study.
  • STD-R was categorized as worsened, incomplete, or complete 90 minutes post-primary percutaneous coronary intervention (PCI).
  • Major adverse cardiac events (MACE) were tracked for 12 months.

Main Results:

  • Worsened or incomplete STD-R correlated with larger area at risk, infarct size, and microvascular obstruction, alongside lower LVEF.
  • Patients with incomplete or worsened STD-R had significantly higher MACE rates.
  • Categorized STD-R independently predicted MACE at 12 months in multivariate analysis.

Conclusions:

  • Incomplete STD-R after PCI in STEMI signifies more substantial myocardial and microvascular damage.
  • STD-R provides independent prognostic information regarding MACE over a 12-month follow-up.
  • CMR assessment combined with STD-R offers valuable prognostic insights in STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
451
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
751